The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Open accessAbstract
The amide functional group plays a key role in the composition of biomolecules, including many clinically approved drugs. Bioisosterism is widely employed in the rational modification of lead compounds, being used to increase potency, enhance selectivity, improve pharmacokinetic properties, eliminate toxicity, and acquire novel chemical space to secure intellectual property. The introduction of a bioisostere leads to structural changes in molecular size, shape, electronic distribution, polarity, pKa, dipole or polarizability, which can be either favorable or detrimental to biological activity. This approach has opened up new avenues in drug design and development resulting in more efficient drug candidates introduced onto the market as well as in the clinical pipeline. Herein, we review the strategic decisions in selecting an amide bioisostere (the why), synthetic routes to each (the how), and success stories of each bioisostere (the implementation) to provide a comprehensive overview of this important toolbox for medicinal chemists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Peptide therapeutics: current status and future directions
Fosgerau, K., & Hoffmann, T. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.003 · Cited by 3,030
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Amide bond formation: beyond the myth of coupling reagents
Valeur, E., & Bradley, M. (2009) · Chem. Soc. Rev. · doi:10.1039/b701677h · Cited by 2,198
Rethinking amide bond synthesis
Pattabiraman, V. R., & Bode, J. W. (2011) · Nature · doi:10.1038/nature10702 · Cited by 2,164
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879
Khandpur, R., Carmona-Rivera, C., Vivekanandan-Giri, A., Gizinski, A., Yalavarthi, S., Knight, J. S., Friday, S., Li, S., Patel, R. M., Subramanian, V., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005580 · Cited by 1,337
Bioisosterism: A Rational Approach in Drug Design
Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,328
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
Russell, F. A., King, R., Smillie, S.-J., Kodji, X., & Brain, S. D. (2014) · Physiological Reviews · doi:10.1152/physrev.00034.2013 · Cited by 1,258
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Tron, G. C., Pirali, T., Billington, R. A., Canonico, P. L., Sorba, G., & Genazzani, A. A. (2008) · Medicinal Research Reviews · doi:10.1002/med.20107 · Cited by 996
Nonclassical Routes for Amide Bond Formation
de Figueiredo, R. M., Suppo, J.-S., & Campagne, J.-M. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00237 · Cited by 978
2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products
Borthwick, A. D. (2012) · Chemical Reviews · doi:10.1021/cr200398y · Cited by 880
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875
Large-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals
Dunetz, J. R., Magano, J., & Weisenburger, G. A. (2016) · Organic Process Research & Development · doi:10.1021/op500305s · Cited by 819
Biological role of matrix metalloproteinases: a critical balance
Löffek, S., Schilling, O., & Franzke, C.-W. (2011) · European Respiratory Journal · doi:10.1183/09031936.00146510 · Cited by 756
Future directions for peptide therapeutics development
Kaspar, A. A., & Reichert, J. M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.011 · Cited by 750
The 1,2,3-triazole ring as a bioisostere in medicinal chemistry
Bonandi, E., Christodoulou, M. S., Fumagalli, G., Perdicchia, D., Rastelli, G., & Passarella, D. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.014 · Cited by 743
Organic Carbamates in Drug Design and Medicinal Chemistry
Ghosh, A. K., & Brindisi, M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501371s · Cited by 739
Wong, G. T., Manfra, D., Poulet, F. M., Zhang, Q., Josien, H., Bara, T., Engstrom, L., Pinzon-Ortiz, M., Fine, J. S., Lee, H.-J. J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311652200 · Cited by 718
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
Lee, A. C.-L., Harris, J. L., Khanna, K. K., & Hong, J.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102383 · Cited by 686
Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design
Lima, L., & Barreiro, E. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363540 · Cited by 672
Benzodiazepine pharmacology and central nervous system-mediated effects.
(2013) · Europe PMC (PubMed Central) · Cited by 650
Summa, V., Petrocchi, A., Bonelli, F., Crescenzi, B., Donghi, M., Ferrara, M., Fiore, F., Gardelli, C., Gonzalez Paz, O., Hazuda, D. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800245z · Cited by 633
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds
Ramesh, R., & Reddy, D. S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00718 · Cited by 624
Oxadiazoles in Medicinal Chemistry
Boström, J., Hogner, A., Llinàs, A., Wellner, E., & Plowright, A. T. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2013248 · Cited by 614
Peptidomimetics via copper-catalyzed azide–alkyne cycloadditions
Angell, Y. L., & Burgess, K. (2007) · Chemical Society Reviews · doi:10.1039/b701444a · Cited by 589
The CB2 receptor and its role as a regulator of inflammation
Turcotte, C., Blanchet, M.-R., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 588
Mu Opioids and Their Receptors: Evolution of a Concept
Pasternak, G. W., & Pan, Y.-X. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 578
Carboxylic Acid (Bio)Isosteres in Drug Design
Ballatore, C., Huryn, D. M., & Smith, A. B. (2013) · ChemMedChem · doi:10.1002/cmdc.201200585 · Cited by 523
Leshner, M., Wang, S., Lewis, C., Zheng, H., Chen, X. A., Santy, L., & Wang, Y. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00307 · Cited by 485
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
Gauthier, J. Y., Chauret, N., Cromlish, W., Desmarais, S., Duong, L. T., Falgueyret, J.-P., Kimmel, D. B., Lamontagne, S., Léger, S., LeRiche, T., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.047 · Cited by 477
Isosterism and molecular modification in drug design
Thornber, C. W. (1979) · Chemical Society Reviews · doi:10.1039/cs9790800563 · Cited by 473
Imatinib: A Breakthrough of Targeted Therapy in Cancer
Iqbal, N., & Iqbal, N. (2014) · Chemotherapy Research and Practice · doi:10.1155/2014/357027 · Cited by 470
Oxetanes in Drug Discovery: Structural and Synthetic Insights
Wuitschik, G., Carreira, E. M., Wagner, B., Fischer, H., Parrilla, I., Schuler, F., Rogers-Evans, M., & Müller, K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9018788 · Cited by 418
Cabral, G. A., & Griffin-Thomas, L. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000957 · Cited by 408
RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution
Venkataraman, S., Prasad, B., & Selvarajan, R. (2018) · Viruses · doi:10.3390/v10020076 · Cited by 403
Adenosine Receptors: Expression, Function and Regulation
Sheth, S., Brito, R., Mukherjea, D., Rybak, L., & Ramkumar, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15022024 · Cited by 401
Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry
Ghosh, A. K., & Brindisi, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01541 · Cited by 401
Melatonin for the prevention and treatment of cancer
Li, Y., Li, S., Zhou, Y., Meng, X., Zhang, J.-J., Xu, D.-P., & Li, H.-B. (2017) · Oncotarget · doi:10.18632/oncotarget.16379 · Cited by 388
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
Sharpe, H. J., Pau, G., Dijkgraaf, G. J., Basset-Seguin, N., Modrusan, Z., Januario, T., Tsui, V., Durham, A. B., Dlugosz, A. A., Haverty, P. M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.001 · Cited by 382
Midazolam A Review of its Pharmacological Properties and Therapeutic Use
Dundee, J. W., Halliday, N. J., Harper, K. W., & Brogden, R. N. (1984) · Drugs · doi:10.2165/00003495-198428060-00002 · Cited by 359
Genomics and the Multifactorial Nature of Human Autoimmune Disease
Cho, J. H., & Gregersen, P. K. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100030 · Cited by 354
Pertwee, R. G. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0381 · Cited by 347
Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications
Trippier, P. C., & McGuigan, C. (2010) · MedChemComm · doi:10.1039/c0md00119h · Cited by 346
Self-citationSelzner, M., Bielawska, A. E., Morse, M. A., Rüdiger, H. A., Sindram, D., Hannun, Y. A., & Clavien, P. (2001) · PubMed · Cited by 334
Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization
Han, D., Handelman, G., Marcocci, L., Sen, C. K., Roy, S., Kobuchi, H., Tritschler, H. J., Flohé, L., & Packer, L. (1997) · BioFactors · doi:10.1002/biof.5520060303 · Cited by 334
Peptidomimetic toolbox for drug discovery
Lenci, E., & Trabocchi, A. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00102c · Cited by 326
Witalison, E., Thompson, P., & Hofseth, L. (2015) · Current Drug Targets · doi:10.2174/1389450116666150202160954 · Cited by 310
Neuronal nicotinic acetylcholine receptor structure and function and response to nicotine
Dani, J. A. (2015) · International Review of Neurobiology · doi:10.1016/bs.irn.2015.07.001 · Cited by 309
Buckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000562 · Cited by 308
Calcitonin Gene‐Related Peptide (CGRP) and Migraine
Durham, P. L. (2006) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00483.x · Cited by 303
Blocking CGRP in migraine patients – a review of pros and cons
On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS), Deen, M., Correnti, E., Kamm, K., Kelderman, T., Papetti, L., Rubio-Beltrán, E., Vigneri, S., Edvinsson, L., & Maassen Van Den Brink, A. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0807-1 · Cited by 298
Direct and indirect antioxidant properties of α‐lipoic acid and therapeutic potential
Rochette, L., Ghibu, S., Richard, C., Zeller, M., Cottin, Y., & Vergely, C. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200608 · Cited by 297
(2004) · PubMed · Cited by 296
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
Jockers, R., Maurice, P., Boutin, J. A., & Delagrange, P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.184 · Cited by 293
The impact of click chemistry in medicinal chemistry
Hou, J., Liu, X., Shen, J., Zhao, G., & Wang, P. G. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.682725 · Cited by 286
Classics in Chemical Neuroscience: Diazepam (Valium)
Calcaterra, N. E., & Barrow, J. C. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000056 · Cited by 281
Heidbreder, C. A., & Newman, A. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05149.x · Cited by 273
Melagraki, G., Afantitis, A., Igglessi-Markopoulou, O., Detsi, A., Koufaki, M., Kontogiorgis, C., & Hadjipavlou-Litina, D. J. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.12.027 · Cited by 272
Pharmacology of imatinib (STI571)
Buchdunger, E., O'Reilley, T., & Wood, J. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80600-1 · Cited by 269
Boron in drug design: Recent advances in the development of new therapeutic agents
Fernandes, G. F. S., Denny, W. A., & Dos Santos, J. L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.092 · Cited by 269
Melatonin in type 2 diabetes mellitus and obesity
Karamitri, A., & Jockers, R. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0130-1 · Cited by 268
An Evaluation of Peptide‐Bond Isosteres
Choudhary, A., & Raines, R. T. (2011) · ChemBioChem · doi:10.1002/cbic.201100272 · Cited by 259
CB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
Dhopeshwarkar, A., & Mackie, K. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094649 · Cited by 257
Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer
Tracz-Gaszewska, Z., & Dobrzyn, P. (2019) · Cancers · doi:10.3390/cancers11070948 · Cited by 248
The neuroprotective role of melatonin in neurological disorders
Alghamdi, B. S. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24220 · Cited by 233
Rational Approach To Discover Multipotent Anti-Alzheimer Drugs
Rosini, M., Andrisano, V., Bartolini, M., Bolognesi, M. L., Hrelia, P., Minarini, A., Tarozzi, A., & Melchiorre, C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049112h · Cited by 226
Makrilakis, K. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16152720 · Cited by 216
Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs
Joyce, J. N. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00139-5 · Cited by 214
Bursavich, M. G., & Rich, D. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010425b · Cited by 208
Small-molecule inhibition of HIV-1 Vif
Nathans, R., Cao, H., Sharova, N., Ali, A., Sharkey, M., Stranska, R., Stevenson, M., & Rana, T. M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1496 · Cited by 198
Gillman, K. W., Starrett, J. E., Parker, M. F., Xie, K., Bronson, J. J., Marcin, L. R., McElhone, K. E., Bergstrom, C. P., Mate, R. A., Williams, R., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1000239 · Cited by 185
Melatonin Receptors on Ovine Pars Tuberalis: Characterization and Autoradiographicai Localization
Morgan, P. J., Williams, L. M., Davidson, G., Lawson, W., & Howell, E. (1989) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1989.tb00068.x · Cited by 177
Cao, J., Zhou, Y., Peng, H., Huang, X., Stahler, S. L., Suri, V., Qadri, A., Gareski, T., Jones, J. E., Hahm, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.245456 · Cited by 170
Novel 5-HT3 antagonists. Indole oxadiazoles
Swain, C. J., Baker, R., Kneen, C., Moseley, J., Saunders, J., Seward, E. M., Stevenson, G., Beer, M., Stanton, J., & Watling, K. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00105a021 · Cited by 168
Falgueyret, J., Desmarais, S., Oballa, R. M., Black, W. C., Cromlish, W. A., Khougaz, K., Lamontagne, S., Massé, F., Riendeau, D., Toulmond, S., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0504961 · Cited by 167
Chemical structure and properties of midazolam compared with other benzodiazepines.
Gerecke, M. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02266.x · Cited by 165
Trifluoromethyl group: an effective xenobiotic function for peptide backbone modification
Zanda, M. (2004) · New Journal of Chemistry · doi:10.1039/b405955g · Cited by 164
Feduccia, A. A., Chatterjee, S., & Bartlett, S. E. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00083 · Cited by 162
Merck & Co. drops osteoporosis drug odanacatib
Mullard, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.207 · Cited by 159
Structural basis of viral RNA-dependent RNA polymerase catalysis and translocation
Shu, B., & Gong, P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602591113 · Cited by 158
Verster, J. C., & Volkerts, E. R. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00003.x · Cited by 157
Paone, D. V., Shaw, A. W., Nguyen, D. N., Burgey, C. S., Deng, J. Z., Kane, S. A., Koblan, K. S., Salvatore, C., Mosser, S. D., Johnston, V. K., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070668p · Cited by 149
Salvatore, C., Hershey, J. C., Corcoran, H. A., Fay, J. F., Johnston, V. K., Moore, E. L., Mosser, S. D., Burgey, C. S., Paone, D. V., Shaw, A. W., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130344 · Cited by 148
CGRP antagonists: unravelling the role of CGRP in migraine
Doods, H. N., Arndt, K., Rudolf, K. D., & Just, S. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.005 · Cited by 144
Moen, M. D., McKeage, K., Plosker, G. L., & Siddiqui, M. A. A. (2007) · Drugs · doi:10.2165/00003495-200767020-00010 · Cited by 144
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K
Black, W. C., Bayly, C. I., Davis, D. E., Desmarais, S., Falgueyret, J., Léger, S., Li, C. S., Massé, F., McKay, D. J., Palmer, J. T., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.071 · Cited by 142
γ‐Secretase inhibitors and modulators for Alzheimer’s disease
Wolfe, M. S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07501.x · Cited by 139
Dörsam, B., & Fahrer, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.019 · Cited by 139
Bioisosterism as a Molecular Diversity Descriptor: Steric Fields of Single “Topomeric” Conformers
CRAMER, R. D. I., Clark, R. D., Patterson, D. E., & Ferguson, A. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960291f · Cited by 135
Phosphoramidates and phosphonamidates (ProTides) with antiviral activity
Ślusarczyk, M., Serpi, M., & Pertusati, F. (2018) · Antiviral chemistry & chemotherapy · doi:10.1177/2040206618775243 · Cited by 133
A map of the amine–carboxylic acid coupling system
Mahjour, B. A., Shen, Y., Liu, W., & Cernak, T. (2020) · Nature · doi:10.1038/s41586-020-2142-y · Cited by 128
Human Adenosine A2A Receptor: Molecular Mechanism of Ligand Binding and Activation
Carpenter, B., & Lebon, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00898 · Cited by 127
Update of human and mouse matrix metalloproteinase families
Jackson, B. C., Nebert, D. W., & Vasiliou, V. (2010) · Human Genomics · doi:10.1186/1479-7364-4-3-194 · Cited by 123
the Montreal Primary HIV (PHI) Cohort Study Group, Oliveira, M., Ibanescu, R.-I., Anstett, K., Mésplède, T., Routy, J., Robbins, M., & BRENNER, B. G. (2018) · Retrovirology · doi:10.1186/s12977-018-0440-3 · Cited by 118
Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety
He, R., Finan, B., Mayer, J. P., & DiMarchi, R. D. (2019) · Molecules · doi:10.3390/molecules24101855 · Cited by 117
Difluoroethylamines as an amide isostere in inhibitors of cathepsin K
Isabel, É., Mellon, C., Boyd, M. J., Chauret, N., Deschênes, D., Desmarais, S., Falgueyret, J., Gauthier, J. Y., Khougaz, K., Lau, C. K., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.070 · Cited by 111
Current drug treatments targeting dopamine D3 receptor
Leggio, G. M., Bucolo, C., Platania, C. B. M., Salomone, S., & Drago, F. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.007 · Cited by 110
Dozio, E., Ruscica, M., Passafaro, L., Dogliotti, G., Steffani, L., Pagani, A., Demartini, G., Esposti, D., FRASCHINI, F., & Magni, P. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.009 · Cited by 109
α-Lipoic Acid Supplementation Prevents Symptoms of Vitamin E Deficiency
Podda, M., Tritschler, H., Ulrich, H., & Packer, L. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2431 · Cited by 107
Mishra, C. B., Kumari, S., Manral, A., Prakash, A., Saini, V., Lynn, A. M., & Tiwari, M. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.057 · Cited by 107
Self-citationHe, P., Ouyang, X.-P., Zhou, S., Yin, W., Tang, C., Laudon, M., & Tian, S. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.04.009 · Cited by 106
Subramanian, V., Knight, J. S., Parelkar, S. S., Anguish, L. J., Coonrod, S. A., Kaplan, M. J., & Thompson, P. R. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501636x · Cited by 102
Adenosine A 2A Receptor Antagonists and Parkinson’s Disease
Shook, B. C., & Jackson, P. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn2000537 · Cited by 101
Rudin, C. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0568 · Cited by 101
Maramai, S., Gemma, S., Brogi, S., Campiani, G., Butini, S., Stark, H., & Brindisi, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00451 · Cited by 99
Applications of amide isosteres in medicinal chemistry
Sun, S., Jia, Q., & Zhang, Z. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.07.033 · Cited by 98
Newman, A. H., Grundt, P., Cyriac, G., Deschamps, J. R., Taylor, M., Kumar, R., Ho, D. D., & Luedtke, R. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900095y · Cited by 90
Identification of a potent and selective non-basic cathepsin K inhibitor
Li, C. S., Deschênes, D., Desmarais, S., Falgueyret, J., Gauthier, J. Y., Kimmel, D. B., Léger, S., Massé, F., McGrath, M. E., McKay, D. J., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.071 · Cited by 88
Chen, C.-A., Sieburth, S. M., Glekas, A., Hewitt, G. W., Trainor, G. L., Erickson‐Viitanen, S., Garber, S., Cordova, B. C., Jeffry, S., & Klabe, R. M. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00079-5 · Cited by 86
Discovery of Oxadiazoyl Tertiary Carbinamine Inhibitors of β-Secretase (BACE-1)
Rajapakse, H. A., Nantermet, P. G., Selnick, H. G., Munshi, S. K., McGaughey, G. B., Lindsley, S. R., Young, M. B., Lai, M., Espeseth, A. S., Shi, X., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm061046r · Cited by 84
Byrns, M. C., & Penning, T. M. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.024 · Cited by 83
The use of bioisosteric groups in lead optimization.
Olesen, P. H. (2001) · PubMed · Cited by 75
The Effect of Various Zinc Binding Groups on Inhibition of Histone Deacetylases 1–11
Madsen, A. S., Kristensen, H. M. E., Lanz, G., & Olsen, C. A. (2013) · ChemMedChem · doi:10.1002/cmdc.201300433 · Cited by 74
Calcitonin Gene-Related Peptide Receptor Antagonists: New Therapeutic Agents for Migraine
Bell, I. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500364u · Cited by 74
Loriot, Y., Fizazi, K. S., Jones, R. J., den Brande, J. V., Molife, R., Omlin, A. G., James, N. D., Baskin-Bey, E. S., Heeringa, M. J., Baron, B., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0101-x · Cited by 73
Bieberich, E., Hu, B., Silva, J., et al. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00049-6 · Cited by 72
Pasquini, S., Botta, L., Semeraro, T., Mugnaini, C., Ligresti, A., Palazzo, E., Maione, S., Marzo, V. D., & Corelli, F. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800552f · Cited by 71
Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models
Tian, S., Laudon, M., Han, L., Gao, J., Huang, F., Yang, Y., & Deng, H. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.80 · Cited by 71
Tactics in Contemporary Drug Design
Meanwell, N. A. (2014) · Topics in medicinal chemistry · doi:10.1007/978-3-642-55041-6 · Cited by 71
Appendino, G., Bacchiega, S., Minassi, A., Cascio, M. G., PETROCELLIS, L. D., & Marzo, V. D. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200703590 · Cited by 71
Ji, Q., Chang, L., Stanczyk, F. Z., Ookhtens, M., Sherrod, A. E., & Stolz, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1593 · Cited by 70
Appendino, G., Bacchiega, S., Minassi, A., Cascio, M. G., PETROCELLIS, L. D., & Marzo, V. D. (2007) · Angewandte Chemie · doi:10.1002/ange.200703590 · Cited by 70
Lebreton, L., Annat, J., Derrepas, P., Dutartre, P., & Renaut, P. P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980431g · Cited by 69
Kikuchi, A., Furutani, T., Azami, H., Watanabe, K., Niimi, T., Kamiyama, Y., Kuromitsu, S., Baskin-Bey, E. S., Heeringa, M. J., Ouatas, T., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0130-5 · Cited by 68
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease
Stocchi, F., Rascol, O., Hauser, R. A., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004003 · Cited by 68
Evelyn, C. R., Bell, J. L., Ryu, J. G., Wade, S. M., Kocab, A. J., Harzdorf, N. L., Showalter, H. D., Neubig, R. R., & Larsen, S. D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.056 · Cited by 67
Recent developments in cathepsin K inhibitor design.
Grabowskal, U., Chambers, T. J., & Shiroo, M. (2005) · PubMed · Cited by 67
Waller, C. F. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-01222-8_1 · Cited by 67
Pasquini, S., Rosa, M. D., Pedani, V., Mugnaini, C., Guida, F., Luongo, L., Chiaro, M. D., Maione, S., Dragoni, S., Frosini, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200476p · Cited by 65
Inflammation and the Redox‐sensitive AGE–RAGE Pathway as a Therapeutic Target in Alzheimer's Disease
Maczurek, A. E., Shanmugam, K., & Münch, G. W. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1433.026 · Cited by 64
Miller, J. H., Presnyak, V., & Smith, H. C. (2007) · Retrovirology · doi:10.1186/1742-4690-4-81 · Cited by 64
Verma, K., Zang, T., Penning, T. M., & Trippier, P. C. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00090 · Cited by 64
Self-citationTailored therapeutics based on 1,2,3-1 H -triazoles: a mini review
Prasher, P., & Sharma, M. (2019) · MedChemComm · doi:10.1039/c9md00218a · Cited by 64
Neuronal Nicotinic Acetylcholine Receptors: Involvement in Alzheimer’s Disease and Schizophrenia
Woodruff‐Pak, D. S., & Gould, T. J. (2002) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582302001001002 · Cited by 62
Patrick, D. A., Gillespie, J. R., McQueen, J., Hulverson, M. A., Ranade, R. M., Creason, S. A., Herbst, Z. M., Gelb, M. H., C, F. S. B. A., & Tidwell, R. R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01163 · Cited by 61
Bioisosteric Replacement as a Tool in Anti-HIV Drug Design
Dick, A., & Cocklin, S. (2020) · Pharmaceuticals · doi:10.3390/ph13030036 · Cited by 61
Wang, H., Huwaimel, B., Verma, K., Miller, J. E., Germain, T., Kinarivala, N., Pappas, D., Brookes, P. S., & Trippier, P. C. (2017) · ChemMedChem · doi:10.1002/cmdc.201700196 · Cited by 58
Self-citationAltman, R. A., Sharma, K. K., Rajewski, L. G., Toren, P. C., Baltezor, M. J., Pal, M., & Karad, S. N. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00085 · Cited by 58
Identification of the molecular switch that regulates access of 5α-DHT to the androgen receptor
Penning, T. M., Bauman, D. R., Jin, Y., & Rižner, T. L. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.007 · Cited by 57
Boateng, C. A., Bakare, O. M., Zhan, J., Banala, A. K., Burzynski, C., Pommier, E., Keck, T. M., Donthamsetti, P., Javitch, J. A., Rais, R., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00776 · Cited by 56
Koufaki, M., Calogeropoulou, T., Detsi, A., Ροδίτης, Α., Kourounakis, A. P., Papazafiri, P., Tsiakitzis, K. C., Gaitanaki, C., Beis, I. D., & Kourounakis, P. N. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010962w · Cited by 55
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease
D’Onofrio, G., Panza, F., Frisardi, V., Solfrizzi, V., Imbimbo, B. P., Paroni, G., Cascavilla, L., Seripa, D., & Pilotto, A. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.645534 · Cited by 53
Mishra, C. B., Manral, A., Kumari, S., Saini, V., & Tiwari, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.06.027 · Cited by 53
Self-citationPasquini, S., Ligresti, A., Mugnaini, C., Semeraro, T., Cicione, L., Rosa, M. D., Guida, F., Luongo, L., Chiaro, M. D., Cascio, M. G., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100123x · Cited by 52
Design and synthesis of 1,2-dithiolane derivatives and evaluation of their neuroprotective activity
Koufaki, M., Kiziridi, C., Nikoloudaki, F., & Alexis, Μ. N. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.036 · Cited by 52
Ali, A., Wang, J., Nathans, R. S., Cao, H., Sharova, N. P., Stevenson, M., & Rana, T. M. (2012) · ChemMedChem · doi:10.1002/cmdc.201200079 · Cited by 51
New insights into small‐molecule inhibitors of Bcr‐Abl
Schenone, S., Bruno, O., Radi, M., & Botta, M. (2009) · Medicinal Research Reviews · doi:10.1002/med.20175 · Cited by 50
Verma, K., Zang, T., Gupta, N., Penning, T. M., & Trippier, P. C. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00163 · Cited by 50
Self-citationArioli, F., Borrelli, S., Colombo, F., Falchi, F., Filippi, I., Crespan, E., Naldini, A., Scalia, G., Silvani, A., Maga, G., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100304 · Cited by 49
Endo, S., Matsunaga, T., Kanamori, A., Otsuji, Y., Nagai, H., Sundaram, K., El-Kabbani, O. A. L., Toyooka, N., Ohta, S., & Hara, A. (2012) · Journal of Natural Products · doi:10.1021/np201002x · Cited by 49
Novel lipoic acid analogues that inhibit nitric oxide synthase
Harnett, J. J., Auguet, M., Viossat, I., Dolo, C., Bigg, D. C. H., & Chabrier, P. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00216-0 · Cited by 48
Nadon, J., Rochon, K., Grastilleur, S., Langlois, G., Dao, T. T. H., Blais, V., Guérin, B., Gendron, L., & Dory, Y. L. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00163 · Cited by 48
Amide Activation in Ground and Excited States
Kovács, E., Rózsa, B. J., Csomos, A., Csizmadia, I. G., & Mucsi, Z. (2018) · Molecules · doi:10.3390/molecules23112859 · Cited by 48
Homology Models of Melatonin Receptors: Challenges and Recent Advances
Pala, D., Lodola, A., Bedini, A., Spadoni, G., & Rivara, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14048093 · Cited by 47
Ribeiro, A. C., Silva, A. M. E., Santa‐Marta, M., Pombo, A., Moniz‐Pereira, J., Gonçalves, J., & Barahona, I. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.823-833.2005 · Cited by 46
Butler, C. R., Ogilvie, K., Martinez-Alsina, L., Barreiro, G., Beck, E. M., Nolan, C. E., Atchison, K. P., Benvenuti, E., Buzon, L. M., Doran, S. D., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01451 · Cited by 45
Balon, R. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000353599 · Cited by 44
In silico applications of bioisosterism in contemporary medicinal chemistry practice
Papadatos, G., & Brown, N. (2013) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1148 · Cited by 42
‘Click’ synthesis of a triazole-based inhibitor of Met functions in cancer cells
Colombo, F., Tintori, C., Furlan, A., Borrelli, S., Christodoulou, M. S., Dono, R., Maina, F., Botta, M., Amat, M., Bosch, J., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.05.078 · Cited by 42
Selecting Good ‘Drug-Like’ Properties to Optimize Small Molecule Blood-Brain Barrier Penetration
Trippier, P. C. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160405112353 · Cited by 42
Self-citationPrevention of alcohol withdrawal seizures with oral diazepam loading.
Devenyi, P., & Harrison, M. (1985) · PubMed · Cited by 41
Haydar, S. N., Ghiron, C., Bettinetti, L., Bothmann, H., Comery, T. A., Dunlop, J., Rosa, S. L., Micco, I., Pollastrini, M., Quinn, J., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.040 · Cited by 41
Revenga, M. D. L. F., Fernández‐Sáez, N., Herrera‐Arozamena, C., Morales-Garcia, J. A., Alonso‐Gil, S., Pérez‐Castillo, A., Caignard, D., Rivara, S., & Rodrı́guez-Franco, M. I. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00245 · Cited by 41
Novel orally active, dibenzazepinone-based γ-secretase inhibitors
Peters, J., Galley, G., Jacobsen, H., Czech, C., David‐Pierson, P., Kitas, E. A., & Ozmen, L. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.078 · Cited by 40
Karad, S. N., Pal, M., Crowley, R. S., Prisinzano, T. E., & Altman, R. A. (2017) · ChemMedChem · doi:10.1002/cmdc.201700103 · Cited by 40
Yin, Y. D., Fu, M., Brooke, D. G., Heinrich, D. M., Denny, W. A., & Jamieson, S. M. F. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00159 · Cited by 38
Current and Emerging Pharmacological Targets for the Treatment of Alzheimer’s Disease
Morsy, A., & Trippier, P. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190744 · Cited by 38
Self-citationZang, T., Verma, K., Chen, M., Jin, Y., Trippier, P. C., & Penning, T. M. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.12.015 · Cited by 37
Self-citationUsing click chemistry toward novel 1,2,3-triazole-linked dopamine D3 receptor ligands
Keck, T. M., Banala, A. K., Slack, R. D., Burzynski, C., Bonifazi, A., Bakare, O. M., Moore, M., Deschamps, J. R., Rais, R., Slusher, B. S., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.017 · Cited by 36
Eckhardt, B. J., & Gulick, R. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00152-0 · Cited by 33
Mugnaini, C., Nocerino, S., Pedani, V., Pasquini, S., Tafi, A., Chiaro, M. D., Bellucci, L., Valoti, M., Guida, F., Luongo, L., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201100573 · Cited by 31
Ferreira, A. K., Tavares, M. T., Pasqualoto, K. F. M., Azevedo, R., Teixeira, S. F., Ferreira, W. A., Bertin, A. M., de-Sá-Júnior, P. L., Barbuto, J. A. M., Figueiredo, C. R., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3441-z · Cited by 30
SAR and Lead Optimization of an HIV-1 Vif-APOBEC3G Axis Inhibitor
Mohammed, I., Parai, M. K., Jiang, X., Sharova, N. P., Singh, G., Stevenson, M., & Rana, T. M. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300037k · Cited by 29
Serrano‐Wu, M. H., Coppola, G. M., Gong, Y., Neubert, A. D., Chatelain, R. E., Clairmont, K. B., Commerford, R., Cosker, T., Daniels, T., Hou, Y. M., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3000512 · Cited by 28
Koelblinger, P., & Lang, R. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s135650 · Cited by 28
Tyrosine Kinase 2 (TYK2) Allosteric Inhibitors To Treat Autoimmune Diseases
Chang, Y., Xu, S., & Ding, K. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01612 · Cited by 27
Scheidt, K. A. (2010) · Nature · doi:10.1038/4651020a · Cited by 26
Mishra, C. B., Gusain, S., Shalini, S., Kumari, S., Prakash, A., Kumari, N., Yadav, A. K., Kumari, J., Kumar, K., & Tiwari, M. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103524 · Cited by 25
Self-citationNordhoff, S., Bulat, S., Cerezo, S., Hill, O., Hoffmann-Enger, B., López-Canet, M., Rosenbaum, C., Rummey, C., Thiemann, M., Matassa, V. G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.078 · Cited by 24
Liang, J., van Abbema, A., Balázs, M., Barrett, K., Berezhkovsky, L., Blair, W. S., Chang, C. C., Delarosa, D., DeVoss, J., Driscoll, J., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.022 · Cited by 24
Larsen, S. D., Hester, M. R., Ruble, J. C., Kamilar, G. M., Romero, D. L., Wakefield, B. D., Melchior, E. P., Sweeney, M. T., & Marotti, K. R. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.044 · Cited by 22
Robinson, G., & Sellers, E. M. (1982) · PubMed Central · Cited by 19
Sheppard, G. S., Florjancic, A. S., Giesler, J. R., Xu, L., Guo, Y. P., Davidsen, S. K., Marcotte, P. A., Elmore, I. N., Albert, D. H., Magoc, T. J., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00597-6 · Cited by 19
Majmudar, J. D., Hahne, K., Hrycyna, C. A., & Gibbs, R. A. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.078 · Cited by 19
Sun, S., Zhang, Z., Vishnumurthy, K., Pokrovskaia, N., Fonarev, J., Jia, Q., Leung, P.-Y., Tran, J., Ratkay, L. G., McLaren, D. G., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.036 · Cited by 19
Nakajima, K., Chatelain, R. E., Clairmont, K. B., Commerford, R., Coppola, G. M., Daniels, T., Forster, C. J., Gilmore, T. A., Gong, Y., Jain, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00173 · Cited by 19
Unlocking Truths of γ-Secretase In Alzheimer'S Disease: What Is the Translational Potential?
Wolfe, M. S. (2014) · Future Neurology · doi:10.2217/fnl.14.35 · Cited by 18
Koufaki, M., Theodorou, E., Alexi, X., & Alexis, Μ. N. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.042 · Cited by 15
Naidu, B. N., Walker, M. A., Sorenson, M. E., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.05.027 · Cited by 15
Furlan, A., Roux, B., Lamballe, F., Conti, F., Issaly, N., Daian, F., Guillemot, J.-F., Richelme, S., Contensin, M., Bosch, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046738 · Cited by 14
Solid-Phase Synthesis of Prenylcysteine Analogs
Donelson, J. L., Hodges, H. B., Henriksen, B. S., Hrycyna, C. A., & Gibbs, R. A. (2009) · The Journal of Organic Chemistry · doi:10.1021/jo8021692 · Cited by 13
Novel Conformationally Constrained Analogues of Agomelatine as New Melatoninergic Ligands
Rami, M., Landagaray, E., Ettaoussi, M., Boukhalfa, K., Caignard, D., Delagrange, P., Berthelot, P., & Yous, S. (2012) · Molecules · doi:10.3390/molecules18010154 · Cited by 10
Cited by
Cu(I)-Catalyzed Click Chemistry in Glycoscience and Their Diverse Applications
Agrahari, A. K., Bose, P., Jaiswal, M. K., Rajkhowa, S., Singh, A. S., Hotha, S., Mishra, N., & Tiwari, V. K. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00920 · Cited by 472
Zhang, Q.-Q., Zhang, W.-J., & Chang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1168848 · Cited by 24
Landry, M. L., Trager, R., Broccatelli, F., & Crawford, J. J. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00071 · Cited by 10
Metadata
- Authors
- Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-07-20
- Volume
- 63
- Issue
- 21
- Pages
- 12290-12358
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3044388665
- Cited by
- 654
- References
- 204
- FWCI
- 17.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.